Eez-Away Relief

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with arthritis, simple backache, and sore, tired muscles.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to apply EEZ-AWAY® generously to the affected area. After application, the product should be allowed to dry completely before re-application. For optimal pain relief, it is recommended to apply EEZ-AWAY® up to five times daily or as needed, ensuring that each application is followed by a drying period.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. Ensure that the product is stored out of reach of children to prevent potential harm. No other contraindications have been identified.

Warnings and Precautions

The application of external heat, such as an electric heating pad, may lead to excessive skin irritation or burns. Healthcare professionals should advise patients to use caution when applying heat to the affected area and to monitor for any signs of skin damage.

Contact with the eyes and mucous membranes must be strictly avoided to prevent irritation or injury. It is essential to instruct patients on proper application techniques to minimize the risk of accidental exposure.

Tight bandaging is contraindicated, as it may impede circulation and exacerbate any underlying conditions. Patients should be informed to apply dressings loosely to ensure adequate blood flow.

Inhalation of the product is prohibited. Healthcare providers should emphasize the importance of using the product only as directed and in a well-ventilated area to avoid respiratory complications.

Side Effects

The application of external heat, such as an electric heating pad, may result in excessive skin irritation or burns. Patients are advised to avoid contact with the eyes and mucous membranes, and to refrain from bandaging tightly. Inhalation of the product should also be avoided.

Caution is warranted when applying the product to wounds or damaged skin. If a rash or irritation occurs, it is recommended that use be discontinued immediately.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Eez-Away Relief (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. It is essential to ensure that children do not have access to the medication to prevent accidental ingestion or misuse.

Geriatric Use

There is no specific information regarding the use of EEZ-AWAY RELIEF in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of EEZ-AWAY RELIEF during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use. Potential risks to the fetus are not clearly defined; therefore, caution is advised when considering the use of this product in pregnant individuals. No specific dosage modifications for pregnant individuals are provided. It is recommended that EEZ-AWAY RELIEF be used only if clearly needed and if the benefits outweigh the risks.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when treating patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Overall, vigilance and prompt intervention are critical in managing any suspected overdosage scenario.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in configurations that ensure optimal handling and storage. It should be stored at room temperature, away from direct sunlight and moisture. To maintain safety, it is essential to keep the product out of reach of children.

Special handling precautions must be observed. The product should not be applied to wounds or damaged skin, and care should be taken to avoid contact with the eyes and mucous membranes. Additionally, it is advised not to bandage the area tightly after application and to avoid inhalation of the product.

Additional Clinical Information

Patients should apply EEZ-AWAY generously to the affected area, allowing it to dry before re-application. For optimal pain relief, it is recommended to apply, let dry, and re-apply up to five times daily or as needed. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Eez-Away Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)